- A New Way Out of the Predicament of Anaplastic Thyroid Carcinoma From Existing Data Analysis
Yikun Zhou et al, 2022, Frontiers in Endocrinology CrossRef - New Insights into Immune Cells and Immunotherapy for Thyroid Cancer
Yujia Tao et al, 2023, Immunological Investigations CrossRef - Poorly differentiated thyroid carcinoma: molecular, clinico-pathological hallmarks and therapeutic perspectives
Valentina CIRELLO et al, 2024, Panminerva Medica CrossRef - TERT promoter mutations in thyroid cancer
Michiko Matsuse et al, 2023, Endocrine Journal CrossRef - Aggressive variants of follicular cell-derived thyroid carcinoma: an overview
Cristina Pizzimenti et al, 2022, Endocrine CrossRef - Leveraging molecular targeted drugs and immune checkpoint inhibitors treat advanced thyroid carcinoma to achieve thyroid carcinoma redifferentiation
Jing-Yang Su, 2024, American Journal of Cancer Research CrossRef - Update on Fundamental Mechanisms of Thyroid Cancer
Alessandro Prete et al, 2020, Frontiers in Endocrinology CrossRef - The Molecular Signature More Than the Site of Localization Defines the Origin of the Malignancy
Antonio Matrone et al, 2019, Frontiers in Oncology CrossRef - Correlation of ThyroSeq Results with Surgical Histopathology in Cytologically Indeterminate Thyroid Nodules
Patrick D. Chin et al, 2020, Endocrine Pathology CrossRef - Evaluation of E-Cadherin and β-Catenin Immunoreactivity for Determining Undifferentiated Cells in Anaplastic Thyroid Carcinoma
Risa Kanematsu et al, 2021, Pathobiology CrossRef - Deep response to a combination of mTOR inhibitor temsirolimus and dual immunotherapy of nivolumab/ipilimumab in poorly differentiated thyroid carcinoma with PTEN mutation: a case report and literature review
Youjin Oh et al, 2024, Frontiers in Endocrinology CrossRef - Novel Therapeutics in Radioactive Iodine-Resistant Thyroid Cancer
Tanner Fullmer et al, 2021, Frontiers in Endocrinology CrossRef - Pre- and Post-operative Circulating Tumoral DNA in Patients With Medullary Thyroid Carcinoma
Raffaele Ciampi et al, 2022, The Journal of Clinical Endocrinology & Metabolism CrossRef